Amlodipine/benazepril

From Wikipedia, the free encyclopedia - View original article

Amlodipine/benazepril
Combination of
AmlodipineCalcium channel blocker
BenazeprilACE inhibitor
Clinical data
Pregnancy cat.D (US)
Legal status-only (US)
RoutesOral
Identifiers
ATC codeNone
PubChemCID 5746247
ChemSpider4676979 YesY
 YesY (what is this?)  (verify)
 
Jump to: navigation, search
Amlodipine/benazepril
Combination of
AmlodipineCalcium channel blocker
BenazeprilACE inhibitor
Clinical data
Pregnancy cat.D (US)
Legal status-only (US)
RoutesOral
Identifiers
ATC codeNone
PubChemCID 5746247
ChemSpider4676979 YesY
 YesY (what is this?)  (verify)

Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva and Sandoz, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besilate) with an angiotensin converting enzyme inhibitor (benazepril).[1] This drug, like similar combinations, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.[2][3]

See also[edit]

References[edit]

External links[edit]